Zobrazeno 1 - 10
of 38
pro vyhledávání: '"H Lumish"'
Publikováno v:
European Heart Journal. 43
Background While hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease affecting 1 in 200–500 people, it is a heterogeneous disease. Only a subset of patients with HCM develop heart failure (HF; prevalence 35–50%). P
Autor:
D. Concha, A. Chung, H. Lumish, J. Batra, G. Sayer, K. Clerkin, J. Raikhelkar, P. Colombo, Y. Naka, F. Latif, K. Takeda, J. Fried, M. Yuzefpolskaya, Y. Kaku, N. Uriel
Publikováno v:
The Journal of Heart and Lung Transplantation. 42:S235
Autor:
J. Batra, V. Topkara, K. Clerkin, F. Latif, J. Fried, J. Raikhelkar, D. Lotan, E. Donald, H. Lumish, K. Oh, M. Yuzefpolskaya, P. Colombo, E. Lin, G. Sayer, N. Uriel
Publikováno v:
The Journal of Heart and Lung Transplantation. 42:S245
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S197
Autor:
Joshua Z. Willey, Hiroo Takayama, C.A. Bravo Carillo, Yuji Kaku, L. Braghieri, Justin Fried, Veli K. Topkara, L. Witer, Melana Yuzefpolskaya, H. Lumish, Koji Takeda, Nir Uriel, A. Javaid, Y. Naka, G.M. Mondellini, Paolo C. Colombo
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S148-S149
Purpose Advanced heart failure predisposes patients to intracardiac thrombus (ICT) formation. There is a paucity of evidence examining the impact of pre-existing left atrial (LA) or left ventricular (LV) thrombi on post-operative outcomes in patients
Autor:
Y. Naka, J.G. Aaron, G.M. Mondellini, L. Braghieri, B. Cagliostro, Nir Uriel, A. Javaid, Kelly Axsom, H. Lumish, Veli K. Topkara, Koji Takeda, Gabriel Sayer, R. Te-Frey, A. Kim, Paolo C. Colombo, A. Sweat, Melana Yuzefpolskaya
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S201-S202
Purpose Driveline infection (DLI) is a major cause of morbidity and mortality of LVAD therapy. Herein, we aimed to study: 1) whether temporal changes in DL care and pump type had influenced the rate of DLIs; and 2) the long-term outcome after DLI dia
Autor:
Peter J. Kennel, Amirali Masoumi, Y. Naka, Ajay J. Kirtane, Koji Takeda, Gabriel Sayer, Justin Fried, Yuji Kaku, Nir Uriel, H. Lumish, Dimitrios Karmpaliotis, Hiroo Takayama
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S406
Purpose The Impella 5.5 system is the newest temporary left ventricular assist device (LVAD) for the treatment of cardiogenic shock (CS). Impella 5.5 aims to improve deliverability and durability over Impella 5.0, but real-world experience with this
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G.M. Mondellini, Paolo C. Colombo, Y. Naka, B. Cagliostro, Arthur R. Garan, G. Parkis, K. Ross, Ryan T. Demmer, Hiroo Takayama, H. Lumish, A.M. Zuver, M.T. Pineda, M. Cevasco, Melana Yuzefpolskaya, Koji Takeda, L. Witer, Justin Fried, Veli K. Topkara
Publikováno v:
The Journal of Heart and Lung Transplantation. 38:S68-S69
Purpose Patients with advanced HF are at increased risk for intra-cardiac thrombus formation. The impact of pre-existing left atrial (LA) or left ventricular (LV) thrombi on post-operative outcomes in LVAD patients is unknown. Methods We retrospectiv